verily glp 1 Verily Closes GLP-1 Data Gaps with Real-World Evidence Lightpath | Solutions | Verily

Over 18 months, the condition occurred in approximately 8 cases per 10,000 GLP-1 users, compared with 4 to 6 cases among comparison groups

Get personalized weight loss & hormone therapy at Simply Thrive Medical

The company plans more than 20 anti-obesity trials, including 10 Phase 3 studies targeted for 2026, as it builds out its obesity franchise

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes The prescribing information for the generic liraglutide injection approved today includes a Boxed Warning to advise health care professionals and patients about the increased risk of thyroid C-cell tumors

(equal to one in 3 U.S

Fitness and lifestyle brands expanding product ecosystems